Tonix Pharmaceuticals at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Tonix Pharmaceuticals takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its sessions focus on vectored vaccine platforms, from design to improving how well they work. The most concrete covers the safety and efficacy of TNX-801, its horsepox-based vaccine platform.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
BiotechSilver sponsor
Biopharmaceutical company whose vaccine work includes TNX-801, a horsepox-based vaccine platform.
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 20
11:30
Working Group: Vectored Vaccine Platforms: from design to improving efficacy
Working Groups · with Kenya Medical Research Institute
Platforms & delivery
Talk
Wed Oct 21
13:15
TNX-801 vaccine platform safety and efficacy
Emerging & Infectious Diseases

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Tonix Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction